Trends in Breast Cancer Survival from 1975 to 1989
Author Information
Author(s): MJ Bradburn, DG Altman, P Smith, IS Fentiman, RD Rubens
Primary Institution: Guy's Hospital, London
Hypothesis
Has the survival of patients with breast cancer changed over the period 1975-89?
Conclusion
Survival rates improved for post-menopausal women with operable breast cancer diagnosed between 1985-89, likely due to increased use of tamoxifen.
Supporting Evidence
- Survival rates for post-menopausal women improved significantly in the 1985-89 cohort compared to earlier cohorts.
- Tamoxifen was commonly prescribed during the later years, correlating with improved survival.
- No significant changes in survival were observed for patients with inoperable cancer.
Takeaway
This study looked at how long women with breast cancer lived from 1975 to 1989 and found that those diagnosed in the later years lived longer, especially if they were treated with a medicine called tamoxifen.
Methodology
Retrospective cohort study comparing survival rates of breast cancer patients diagnosed between 1975 and 1989, divided into cohorts based on diagnosis year.
Potential Biases
Potential bias due to the exclusion of patients with unknown menstrual status and the retrospective nature of the study.
Limitations
The study only included patients from a single center and excluded those with in situ tumors or unknown menstrual status.
Participant Demographics
The study included 2604 women diagnosed with invasive breast cancer, with a mix of premenopausal and postmenopausal patients.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI 0.51-0.78
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website